CSIMarket
 
111 Inc   (YI)
Other Ticker:  
 
 
Price: $1.0800 $-0.02 -1.818%
Day's High: $1.15 Week Perf: -2.7 %
Day's Low: $ 1.08 30 Day Perf: -16.92 %
Volume (M): 13 52 Wk High: $ 3.36
Volume (M$): $ 14 52 Wk Avg: $1.92
Open: $1.08 52 Wk Low: $0.97



 Market Capitalization (Millions $) 182
 Shares Outstanding (Millions) 169
 Employees 3,238
 Revenues (TTM) (Millions $) 2,105
 Net Income (TTM) (Millions $) -50
 Cash Flow (TTM) (Millions $) -13
 Capital Exp. (TTM) (Millions $) 1

111 Inc
111 Inc, also known as 111, is a leading digital healthcare platform company in China that aims to provide innovative, integrated solutions to customers and partners in the healthcare industry. The company was founded in Shanghai in 2010 and has since expanded to become one of the largest digital healthcare platforms in China.

111 operates several business segments that are designed to cater to the various needs of its customers. The company's main business segments are:

Pharmacy and healthcare services - this segment provides customers with online and offline healthcare services and prescription drug delivery services. The company operates a network of licensed drug stores and medical clinics that offer a range of healthcare services.

B2B pharmaceutical supply chain - this segment connects pharmaceutical manufacturers, distributors, hospitals and other healthcare providers through its digital platform, providing an integrated supply chain solution.

Insurance and healthcare management - a business segment that focuses on providing insurance companies with health management services and insurance products.

111's core services include providing pharmacy and healthcare services, a digital hospital platform and B2B pharmaceutical supply chain services. The company's digital hospital platform operates through its subsidiary DXY, which is a platform that connects patients, doctors and hospitals through its online and offline services. DXY is one of the largest online medical portals in China with over 20 million registered users.

In addition to its core services, 111 has also developed a range of innovative technology products that enhance its service offering. For example, the company's AI technology and big data analytics are used to improve patient experience and improve healthcare outcomes.

111 has a strong presence in China's major cities and has expanded to over 30 provinces and municipalities, covering over 90% of China's population. The company has also established strategic partnerships with leading pharmaceutical companies and healthcare providers in China.

111 Inc is listed on the NASDAQ exchange under the ticker symbol YI. The company has won several awards, including being recognized as an innovative company at the 2019 World Artificial Intelligence Conference.


   Company Address: 3-4/F, No.295 ZuChongZhiRoad, Shanghai 201203
   Company Phone Number: 21 2053-6666   Stock Exchange / Ticker: NASDAQ YI
   


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
• View Complete Report
   



Petmed Express Inc

Despite Revenue Growth, Petmed Express Inc Faces Growing Deficit Concerns

Petmed Express Inc, a well-known nationwide pet pharmacy, has recently seen a decrease in its share price over the course of June. This decline has resulted in the share price dropping by -1.64% in just one month, bringing the overall decrease to -16.53% in the past 90 days. Additionally, the company's shares are currently only trading 6.9% above its 52-week low.
Despite these negative trends in the stock price, Petmed Express Inc has actually seen an increase in revenue of 11.248% compared to the same financial reporting period a year ago, with revenue reaching $68.18 million for the financial time-frame ending March 31, 2024. However, despite this increase in revenue, the company has also reported an increase in its deficit per share, with a deficit of $-0.12 per share in the most recent financial period. This is an increase from a deficit of $-0.10 per share in the prior reporting period.

Trxade Health Inc

Extremely difficult quarter for the company during the October to December 31 2023 three months

MEDS disclosed disastrous Dec 31 2023 report, where Revenue faded by -59.069 % to $1.04 million and net loss per share has swelled to $-17.13, from the comparable quarter a year before. The deterioration of revenue is relative to relative to all in all Pharmacy Services and Retail Drugstore industry, which posted a top-line improvement during the same period.

Hwh International Inc

Headline: The company Hwh International Inc reveals impressive first quarter revenue of $0.28611 million in latest financial report



Hwh International Inc has released its financial report for the first quarter of 2024, detailing its revenue and earnings for the period. This report highlights the company's revenue generation and profitability, as well as recent stock performance.
Revenue and Net Loss:
During the first quarter of 2024, Hwh International Inc recorded revenue of $0.28611 million. This figure represents the total amount earned by the company during this period. In comparison, the same quarter in the previous year did not generate any revenue, indicating a significant improvement for Hwh International Inc. However, despite the increase in revenue, the company experienced a net loss of $-1.337 million. This loss can be concerning, as it indicates a decline in profitability compared to the same period last year, during which the company reported zero gain.

111 Inc

Very balanced rise for the 111 Inc all along the October to December 31 2023 fiscal period

For the October to December 31 2023 fiscal period YI lost money of $-0.33 per share compare to $-0.36 a year prior and from $0.00 per share from the prior quarter. The Revenue advanced by 7.433 % to $2.11 billion from $1.96 billion in the same quarter a year prior and sequentially from $0.00 million. But the YIs' top-line increase below thePharmacy Services and Retail Drugstore industry contemporaries, had the 12.76% from the same quarter a year ago top-line rise.

Mckesson Corporation

Mckesson Corporation's Revenue Soars in Latest Fiscal Report

McKesson Corporation (NYSE: MCK) has recently released its fiscal 2024 fourth quarter financial results, showcasing impressive numbers in revenue and earnings per share. During this earnings season, McKesson reported a revenue of $76.36 billion, representing a year-on-year increase of 10.804%. Earnings per share also advanced by 5.51% to $6.05.
What sets McKesson apart from its peers in the Pharmacy Services and Retail Drugstore sector is its exceptional revenue growth. While its industry counterparts reported an average top-line improvement of 5.59% in the fourth quarter of 2024, McKesson's revenue growth outpaced them significantly. This demonstrates the company's ability to capture a larger share of the market.






 

111 Inc's Segments
 
 
• View Complete Report
  Company Estimates  
  Revenue Outlook
111 Inc does not provide revenue guidance.

Earnings Outlook
111 Inc does not provide earnings estimates.

 
Geographic Revenue Dispersion




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com